title: More on: Fluvastatin inhibits upregulation of tissue factor expression by antiphospholipid antibodies on endothelial cells.
authors.forename: J
authors.initials: J
authors.lastname: Musial
authors.forename: D
authors.initials: D
authors.lastname: Rys
authors.forename: J
authors.initials: J
authors.lastname: Brozek
authors.forename: J
authors.initials: J
authors.lastname: Swadzba
authors.forename: T
authors.initials: T
authors.lastname: Iwaniec
mesh_terms: D017152:Antibodies, Antiphospholipid / Q000502:physiology*; D016736:Antiphospholipid Syndrome / Q000188:drug therapy; D000075202:Contraindications; D004730:Endothelium, Vascular / Q000737:chemistry; D005229:Fatty Acids, Monounsaturated / Q000008:administration & dosage / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D000077340:Fluvastatin; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D007211:Indoles / Q000008:administration & dosage / Q000494:pharmacology; D013925:Thromboplastin / Q000037:antagonists & inhibitors*; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D017152:Antibodies, Antiphospholipid; D005229:Fatty Acids, Monounsaturated; D005343:Fibrinolytic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007211:Indoles; D000077340:Fluvastatin; D013925:Thromboplastin